Lv3
390 积分 2022-09-28 加入
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials
18天前
已完结
High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease
1个月前
已完结
Efficacy of mepolizumab and omalizumab combination therapy in uncontrolled asthma
1个月前
已完结
Dual biologics therapy in a patient with severe asthma and chronic urticaria: a case report and review of the literature
1个月前
已完结
Improving sleep in severe CRSwNP: an RCT on the effect of mepolizumab and FESS on OSA, sleep disturbances and quality of life
1个月前
已完结
Cellular and molecular mechanisms of asthma and COPD
1个月前
已完结
Two-Year Turning Point With Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Control, Remission, and Tapering Dosage
2个月前
已完结
Interactions between COPD and outcomes after percutaneous coronary intervention
2个月前
已完结
Chronic Rhinosinusitis Optimisation of Nasal Outcomes and Scores (CHRONOS): An Italian Delphi Consensus on Long-Term Management with Biologics
2个月前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
4个月前
已完结
皖公网安备34019202002308
